WOONSOCKET - CVS Health Corp (NYSE:CVS) saw its stock value climb today, reaching $81.54, buoyed by the company's reaffirmed financial outlook for the fiscal year 2023. The healthcare giant expressed confidence in achieving the higher end of its projected adjusted earnings per share (EPS), which is anticipated to fall between $8.50 and $8.70.
The optimism from CVS Health stems partly from its successful strategies in sales and retention, leading to a projected increase in Medicare Advantage plan enrollments for 2024. This expected growth highlights the company's effectiveness in navigating the competitive healthcare plan market.
In addition to its EPS forecast, CVS Health is also targeting the upper end of its operational cash flow guidance for the year, aiming to reach between $12.5 billion and $13.5 billion.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.